Ono Venture Investment, Inc.
Ono Venture Investment, Inc. (OVI) is the corporate venture capital arm of Ono Pharmaceutical Co.,Ltd. , an R&D-oriented pharmaceutical company succeeded in delivery of “First in class” medicines to patients such as OPDIVO® (nivolumab).
Address
South San FranciscoCA
United States
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}